Literature DB >> 3104386

The effect of cost sharing on the use of antibiotics in ambulatory care: results from a population-based randomized controlled trial.

B Foxman, R B Valdez, K N Lohr, G A Goldberg, J P Newhouse, R H Brook.   

Abstract

Little is known about how generosity of insurance and population characteristics affect quantity or appropriateness of antibiotic use. Using insurance claims for antibiotics from 5765 non-elderly people who lived in six sites in the United States and were randomly assigned to insurance plans varying by level of cost-sharing, we describe how antibiotic use varies by insurance plan, diagnosis and health status, geographic area, and demographic characteristics. People with free medical care used 85% more antibiotics than those required to pay some portion of their medical bills (controlling for all other variables). Antibiotic use was significantly more common among women, the very young, patients with poorer health, and persons with higher income. Use of antibiotics for viral, viral-bacterial, and bacterial conditions did not differ between free and cost-sharing insurance plans, given antibiotics were the treatment of choice. Cost sharing reduced inappropriate and appropriate antibiotic use to a similar degree.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104386     DOI: 10.1016/0021-9681(87)90176-7

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  10 in total

Review 1.  The effect of managed care on prescription drug costs and benefits.

Authors:  A Lyles; F B Palumbo
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

2.  Charging the patient to save the system? Like bailing water with a sieve.

Authors:  Stephen Birch
Journal:  CMAJ       Date:  2004-06-08       Impact factor: 8.262

3.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

4.  Impact of consumer fees on drug utilisation.

Authors:  D G Smith; D M Kirking
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

5.  Prescription cost sharing: economic and health impacts, and implications for health policy.

Authors:  R A Levy
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

6.  The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.

Authors:  R E Johnson; M J Goodman; M C Hornbrook; M B Eldredge
Journal:  Health Serv Res       Date:  1997-04       Impact factor: 3.402

7.  Ambulatory antibiotic use and prescription drug coverage in older adults.

Authors:  Yuting Zhang; Bruce Y Lee; Julie M Donohue
Journal:  Arch Intern Med       Date:  2010-08-09

8.  Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review.

Authors:  Sara C Keller; Pranita D Tamma; Sara E Cosgrove; Melissa A Miller; Heather Sateia; Julie Szymczak; Ayse P Gurses; Jeffrey A Linder
Journal:  J Am Board Fam Med       Date:  2018 May-Jun       Impact factor: 2.657

9.  A retrospective audit of antibiotic prescriptions in primary health-care facilities in Eastern Region, Ghana.

Authors:  Mary-Anne Ahiabu; Britt P Tersbøl; Richard Biritwum; Ib C Bygbjerg; Pascal Magnussen
Journal:  Health Policy Plan       Date:  2015-06-04       Impact factor: 3.344

10.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.